AndreaBozzo/ceres-open-data-index huggingface dataset:
Plan ID Crosswalk PUF - PY2019

The Plan ID Crosswalk PUF (CW-PUF) is one of the files that make up the Marketplace PUF. The purpose of the CW-PUF is to map QHPs and SADPs offered through the Marketplaces in 2018 to plans that will be offered through the Marketplaces in 2019. These data either originate from the Plan Crosswalk template (i.e., template field), an Excel-based form used by issuers to describe their plans in the QHP application process, or were generated by CCIIO for use in data processing (i.e., system-generated).This data dictionary describes the variables contained in the CW-PUF. Each record relates to a mapping between a plan offered in 2018 and a plan offered in 2019 at the county or county-zip code level.
Patent AT-E401832-T1: [Translated] DISPOSABLE DENTAL INSTRUMENT

The instrument has a sleeve (2) comprising a metal body or core (3) and a sheath (4) surmounted around the metal body or core. The sheath distorts under the effect of a type of sterilization or disinfection such as sterilization by dry heat, by steam or sterilization with ethylene oxide, currently utilized by a practitioner. The sheath is made of material whose melting point is lower than 90[deg]Celsius.
Patent AT-E400147-T1: [Translated] MOBILE NETWORKS WITH ATM SWITCHING

The invention relates to telecommunication networks and particularly to mobile networks using Asynchronous Transfer Mode (ATM) transmission systems. The invention also relates to the control of mobility and call control functions in ATM systems. According to the invention, a network element (MSC/BSC) of a telecommunication network, such as a mobile network, which in a conventional telecommunication network architecture ensures the switching of circuit-switched connections, is provided with an ATM switching function. ATM switching functions are controlled with the same call and switching control operations (31) that are conventionally used e.g. for the control of a TDM switching field (32) in a PLMN network element. In a minimum implementation, an ATM switching field (301) provided with a suitable control interface (30) is simply arranged in place of or parallel with the TDM switching field. The switching network element thus becomes an ATM network node of a physical or a logical interface layer. PLMN level signalling, mobility management and call control are implemented using solutions offered by existing mobile networks and current PLMN network elements.
Compound 526804: 2-Hydroxy-arachidic, methyl ester, 2-tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 2-[tert-butyl(dimethyl)silyl]oxyicosanoate. Molecular Formula: C27H56O3Si. Molecular Weight: 456.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1AA.  Poliovirus infection, nonparalytic to Psittacosis

NNDSS - TABLE 1AA.  Poliovirus infection, nonparalytic to Psittacosis - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 525559: 1-Pentanamine, N-(phenylmethylene)-

Chemical compound data from PubChem database. IUPAC Name: N-pentyl-1-phenylmethanimine. Molecular Formula: C12H17N. Molecular Weight: 175.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530474: m-Toluic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 3-methylbenzoate. Molecular Formula: C20H26O2. Molecular Weight: 298.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400707-T1: [Translated] CLOCKING TOOTH

The tooth (10) includes a pivot bearing (12) which pivotally supports a pivot pin on a cutting wheel hub. A cutting tooth support (20) and a steering arm (30) extend from the pivot bearing, to opposite directions. The pivot bearing, the cutting tooth support, and the steering arm are designed as a one-piece support. Independent claims are also included for the following: (A) a cutting wheel; and (B) a trench cutter.
2010 State Profile — Vermont

This state profile includes data from facilities in Vermont that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in Vermont. In Vermont, 42 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 4,489 clients in substance abuse treatment on March 31, 2010. The survey response rate in Vermont was 95.7%.
Patent AT-E401672-T1: [Translated] PREPARATION OF A POLYMERIC DEVICE

A method of forming a polymer device including the steps (i) of depositing on a substrate a solution containing a polymer or oligomer and a crosslinking moiety, to form a layer, and, (ii) curing the layer formed in step (i) under conditions to form an insoluble crosslinked polymer, wherein the crosslinking moiety is present in step (i) in an amount in the range of from 0.05 mol % to 5 mol % based on the total number of moles or repeat units of the polymer or oligomer and the crosslinking moiety in the solution.
Compound 527130: 2,4,8-Dichloro-dibenzothiophene

Chemical compound data from PubChem database. IUPAC Name: 2,4,8-trichlorodibenzothiophene. Molecular Formula: C12H5Cl3S. Molecular Weight: 287.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA DataTable 5. First Use of Marijuana among Persons Aged 12 or Older, by State and Substate Regions: Average Annual Rates Based on 2010, 2011, and 2012 NSDUHs

Publications Using SAMHSA DataTable 5. First Use of Marijuana among Persons Aged 12 or Older, by State and Substate Regions: Average Annual Rates Based on 2010, 2011, and 2012 NSDUHs
Prone positioning does not affect cannula function during extracorporeal membrane oxygenation or continuous renal replacement therapy

Introduction
          Prone positioning in respiratory failure has been shown to be a useful adjunct in the treatment of severe hypoxia. However, the prone position can result in dislodgment or malfunction of tubes and cannulae. Certain patients receiving extracorporeal membrane oxygenation (ECMO) or continuous renal replacement therapy (CRRT) may also benefit from positional therapy. The impact of cannula-related complications in these patients is potentially disastrous. The safety and efficacy of prone positioning of these patients has not been previously reported.
        
        
          Materials and methods
          A retrospective chart review evaluated ECMO or CRRT cannula location, and displacement or malfunction during positional change or while prone. The study was set in a General Surgery and Trauma Intensive Care Unit. The subjects were all patients at our institution who simultaneously underwent ECMO or CRRT and prone positioning from July 1996 to July 2001. There were no interventions.
        
        
          Results
          Ten patients underwent ECMO and 42 patients underwent CRRT during the study period. Seven patients underwent simultaneous prone positioning and either ECMO (4/10) or CRRT (4/42). A total of 68 turning events (prone to supine or supine to prone) were recorded, with each patient averaging 9.7 (range, 4–16) turning episodes. Turning was performed with sheets and extra nursing personnel; no special mechanical assist devices were used. No patients experienced inadvertent cannula removal during turning. Two patients had poor flow through their cannulae. In one patient, this occurred in the supine position and required repositioning of the cannula. In the second patient, cannulae were changed twice and flow was poor in both the supine and the prone positions. All ECMO and CRRT patients received venous cannulae. Cannula location (seven internal jugular and 11 femoral) did not the affect risk of malfunction.
        
        
          Discussion and conclusions
          Patients with venous cannulae for ECMO or CRRT can be safely placed in the prone position. Flow rates are maintained in this position. Potential cannula complications of ECMO and CRRT are not a contraindication to prone positioning in severely ill patients.
Electronic Health Information Legal Epidemiology Protocol 2014

Authors: Cason Schmit, JD, Gregory Sunshine, JD, Dawn Pepin, JD, MPH, Tara Ramanathan, JD, MPH, Akshara Menon, JD, MPH, Matthew Penn, JD, MLIS
The Health Information Technology for Economic and Clinical Health Act, adopted in 2009, accelerated adoption of electronic health record systems among health care providers. Many state statutes and regulations authorize and define the use of electronic health information (EHI). Practitioners often criticize these laws as complex and contradictory and point to them as barriers to using EHI. Attorney researchers used WestlawNext to search for EHI-related statutes and regulations of the US states, US
territories, and the District of Columbia in effect as of January 2014. The researchers independently catalogued provisions by the EHI use described in the law. This research protocol accompanies the data set, Electronic Health Information Legal Epidemiology Data Set 2014.
Compound 526088: Heneicosanoic acid, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl henicosanoate. Molecular Formula: C24H50O2Si. Molecular Weight: 398.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528891: Cyclobarbital M (OH,-H2O)

Chemical compound data from PubChem database. IUPAC Name: 5-cyclohexa-1,3-dien-1-yl-5-ethyl-1,3-diazinane-2,4,6-trione. Molecular Formula: C12H14N2O3. Molecular Weight: 234.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 CMHS Uniform Reporting System (URS) Table for Georgia

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Georgia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528134: 3-Methyl-5-(2-methylpentyl)-2-(phenylthio)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-5-(2-methylpentyl)-2-phenylsulfanylpyrazine. Molecular Formula: C17H22N2S. Molecular Weight: 286.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable

NNDSS - TABLE 1S. Invasive pneumococcal disease, all ages, Confirmed to Invasive pneumococcal disease, all ages, Probable - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data). 
§ Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.
Publication bias in gastroenterological research – a retrospective cohort study based on abstracts submitted to a scientific meeting

Background
          The aim of this study was to examine the determinants of publication and whether publication bias occurred in gastroenterological research.
        
        
          Methods
          A random sample of abstracts submitted to DDW, the major GI meeting (1992–1995) was evaluated. The publication status was determined by database searches, complemented by a mailed survey to abstract authors. Determinants of publication were examined by Cox proportional hazards model and multiple logistic regression.
        
        
          Results
          The sample included abstracts on 326 controlled clinical trials (CCT), 336 other clinical research reports (OCR), and 174 basic science studies (BSS). 392 abstracts (47%) were published as full papers. Acceptance for presentation at the meeting was a strong predictor of subsequent publication for all research types (overall, 54% vs. 34%, OR 2.3, 95% CI 1.7 to 3.1). In the multivariate analysis, multi-center status was found to predict publication (OR 2.8, 95% CI 1.6–4.9). There was no significant association between direction of study results and subsequent publication. Studies were less likely to be published in high impact journals if the results were not statistically significant (OR 0.5, 95 CI 95% 0.3–0.6). The author survey identified lack of time or interest as the main reason for failure to publish.
        
        
          Conclusions
          Abstracts which were selected for presentation at the DDW are more likely to be followed by full publications. The statistical significance of the study results was not found to be a predictor of publication but influences the chances for high impact publication.
ICU Cornerstone: Changing our view of blood transfusions

Blood transfusions are commonly administered to critically ill patients, but deciding when to transfuse a particular patient is often difficult and necessitates careful consideration of both the potential benefits and risks. This commentary briefly discusses some of the considerations both for and against blood transfusion in the setting of critical illness and reviews a landmark clinical trial in this area. Finally, we reflect on the changes in attitudes towards the transfusion of blood and blood products that have taken place over the last 20 years.
Carpal alignment in distal radial fractures

Background
          Carpal malalignment following the malunited distal radial fracture is described to develop as an adaptation to realign the hand to the malunion. It worsens gradually after healing of the fracture due to continued loading of the wrist. It is also reported to develop during the immobilization itself rather than after fracture healing. The present work was aimed to study the natural course and the quantitative assessment of such adaptive carpal realignment following distal radial fracture.
        
        
          Methods
          In a prospective study, 118 distal radial fractures treated with different modalities were followed-up with serial radiographs for a year for assessment of various radiological parameters.
        
        
          Results
          Two patterns of carpal malalignment were identified depending upon the effective radio-lunate flexion (ERLF) measured on pre-reduction radiographs. The midcarpal malalignment was seen in 98 radial fractures (83%) with the lunate following the dorsiflexed fracture fragment and a measured ERLF of less than 25°. The second pattern of radio-carpal malalignment showed the fracture fragment to dorsiflex without taking the lunate with a measured ERLF of more than 25°. The scaphoid did not follow the fracture fragment in both the patterns of malalignment.
        
        
          Conclusion
          It is better to assess distal radial fractures for any wrist ligamentous injury on the post-reduction film with the restored radial anatomy than on the pre-reduction film since most carpal malalignments get corrected with the reduction of the fracture. Similar carpal malalignment reappear with the redisplacement of the fracture as seen in pre-reduction radiographs and develops during the immobilization rather than as a later compensatory mechanism for the malunion.
Compound 526289: 1,4,6,7-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,4,6,7-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Azithromycin

Azithromycin is an antibiotic used to treat bacterial infections like ear infections, respiratory tract infections, and skin infections. It comes as an oral suspension (powder to mix) in strengths of 100 mg or 200 mg per 5 mL. Manufactured by Zydus Lifesciences under ANDA211147, it's a prescription drug. This information was generated using AI and is provided for informational and research purposes only.
Compound 526457: Hexyl perfluoropentanoate

Chemical compound data from PubChem database. IUPAC Name: hexyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate. Molecular Formula: C11H13F9O2. Molecular Weight: 348.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526735: 2-(2-Nonoxyethoxy)ethanol

Chemical compound data from PubChem database. IUPAC Name: 2-(2-nonoxyethoxy)ethanol. Molecular Formula: C13H28O3. Molecular Weight: 232.36. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Table 20. 2011-2012 NSDUH Dependence or Abuse of Illicit Drugs or Alcohol in the Past Year, by Age Group and State

Table 20. Dependence or Abuse of Illicit Drugs or Alcohol in the Past Year, by Age Group and State: Percentages, Annual Averages Based on 2011 and 2012 NSDUHs. Results are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528629: N-cyclohexyl-2,2-dimethylpropanamide

Chemical compound data from PubChem database. IUPAC Name: N-cyclohexyl-2,2-dimethylpropanamide. Molecular Formula: C11H21NO. Molecular Weight: 183.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Connecticut 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.